JP2022508716A5 - - Google Patents

Info

Publication number
JP2022508716A5
JP2022508716A5 JP2021545287A JP2021545287A JP2022508716A5 JP 2022508716 A5 JP2022508716 A5 JP 2022508716A5 JP 2021545287 A JP2021545287 A JP 2021545287A JP 2021545287 A JP2021545287 A JP 2021545287A JP 2022508716 A5 JP2022508716 A5 JP 2022508716A5
Authority
JP
Japan
Prior art keywords
protein
mutant
virus
deaminase
nucleotide
Prior art date
Application number
JP2021545287A
Other languages
English (en)
Japanese (ja)
Other versions
JP7588856B2 (ja
JPWO2020081568A5 (https=
JP2022508716A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056341 external-priority patent/WO2020081568A1/en
Publication of JP2022508716A publication Critical patent/JP2022508716A/ja
Publication of JPWO2020081568A5 publication Critical patent/JPWO2020081568A5/ja
Publication of JP2022508716A5 publication Critical patent/JP2022508716A5/ja
Priority to JP2024107552A priority Critical patent/JP2024121000A/ja
Application granted granted Critical
Publication of JP7588856B2 publication Critical patent/JP7588856B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021545287A 2018-10-15 2019-10-15 Nme2Cas9-デアミナーゼ融合タンパク質によるブログラム可能なDNA塩基編集 Active JP7588856B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024107552A JP2024121000A (ja) 2018-10-15 2024-07-03 Nme2Cas9-デアミナーゼ融合タンパク質によるブログラム可能なDNA塩基編集

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862745666P 2018-10-15 2018-10-15
US62/745,666 2018-10-15
PCT/US2019/056341 WO2020081568A1 (en) 2018-10-15 2019-10-15 Programmable dna base editing by nme2cas9-deaminase fusion proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024107552A Division JP2024121000A (ja) 2018-10-15 2024-07-03 Nme2Cas9-デアミナーゼ融合タンパク質によるブログラム可能なDNA塩基編集

Publications (4)

Publication Number Publication Date
JP2022508716A JP2022508716A (ja) 2022-01-19
JPWO2020081568A5 JPWO2020081568A5 (https=) 2022-09-20
JP2022508716A5 true JP2022508716A5 (https=) 2022-09-20
JP7588856B2 JP7588856B2 (ja) 2024-11-25

Family

ID=68621349

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021545287A Active JP7588856B2 (ja) 2018-10-15 2019-10-15 Nme2Cas9-デアミナーゼ融合タンパク質によるブログラム可能なDNA塩基編集
JP2024107552A Pending JP2024121000A (ja) 2018-10-15 2024-07-03 Nme2Cas9-デアミナーゼ融合タンパク質によるブログラム可能なDNA塩基編集

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024107552A Pending JP2024121000A (ja) 2018-10-15 2024-07-03 Nme2Cas9-デアミナーゼ融合タンパク質によるブログラム可能なDNA塩基編集

Country Status (16)

Country Link
US (1) US12577546B2 (https=)
EP (1) EP3867367A1 (https=)
JP (2) JP7588856B2 (https=)
KR (1) KR20210077732A (https=)
CN (1) CN113166743B (https=)
BR (1) BR112021007123A2 (https=)
CA (1) CA3116555A1 (https=)
CO (1) CO2021006336A2 (https=)
EA (1) EA202191033A1 (https=)
IL (2) IL282267B2 (https=)
MX (1) MX2021004301A (https=)
MY (1) MY209774A (https=)
PH (1) PH12021550854A1 (https=)
SG (1) SG11202103722TA (https=)
WO (1) WO2020081568A1 (https=)
ZA (1) ZA202103277B (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
EP3797160A1 (en) 2018-05-23 2021-03-31 The Broad Institute Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
JP7657726B2 (ja) 2019-03-19 2025-04-07 ザ ブロード インスティテュート,インコーポレーテッド 編集ヌクレオチド配列を編集するための方法および組成物
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
DE112021002672T5 (de) 2020-05-08 2023-04-13 President And Fellows Of Harvard College Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
GB202010348D0 (en) 2020-07-06 2020-08-19 Univ Wageningen Base editing tools
CA3204997A1 (en) 2020-12-11 2022-06-16 Intellia Therapeutics, Inc. Compositions and methods for reducing mhc class ii in a cell
CR20230305A (es) 2020-12-11 2023-11-10 Intellia Therapeutics Inc Polinucleótidos, composiciones y métodos para la edición del genoma que implican desaminación
AU2021409732A1 (en) 2020-12-23 2023-07-20 Intellia Therapeutics, Inc. Compositions and methods for reducing hla-a in a cell
TW202242101A (zh) 2020-12-23 2022-11-01 美商英特利亞醫療公司 用於細胞中基因修飾ciita之組合物及方法
EP4426821A1 (en) * 2021-11-02 2024-09-11 University of Massachusetts Nme2cas9 inlaid domain fusion proteins
EP4426822A2 (en) 2021-11-03 2024-09-11 Intellia Therapeutics, Inc. Polynucleotides, compositions, and methods for genome editing
AU2023248451A1 (en) * 2022-04-04 2024-10-17 President And Fellows Of Harvard College Cas9 variants having non-canonical pam specificities and uses thereof
WO2023227669A2 (en) * 2022-05-26 2023-11-30 UCB Biopharma SRL Novel nucleic acid-editing proteins
EP4540389A2 (en) 2022-06-16 2025-04-23 Intellia Therapeutics, Inc. Compositions and methods for reducing mhc class i in a cell
CN119384498A (zh) 2022-06-16 2025-01-28 因特利亚治疗公司 用于对细胞进行遗传修饰的方法和组合物
EP4540388A2 (en) 2022-06-16 2025-04-23 Intellia Therapeutics, Inc. Compositions and methods for genomic editing
CN115206456B (zh) * 2022-07-13 2023-04-25 黑龙江大学 基于属性编辑流的分子生成方法
CN115851775B (zh) * 2022-10-18 2023-08-04 哈尔滨工业大学 一种Cas9蛋白抑制剂及其应用
CN115716880A (zh) * 2022-12-07 2023-02-28 云舟生物科技(广州)股份有限公司 一种核定位荧光蛋白及其应用
WO2024138189A2 (en) 2022-12-22 2024-06-27 Intellia Therapeutics, Inc. Methods for analyzing nucleic acid cargos of lipid nucleic acid assemblies
WO2024186890A1 (en) 2023-03-06 2024-09-12 Intellia Therapeutics, Inc. Compositions and methods for hepatitis b virus (hbv) genome editing
US20240417707A1 (en) * 2023-05-11 2024-12-19 University Of Massachusetts Compositions and methods for improved genome editing with nme2cas9 and nme2-smucas9 variants
AU2024324870A1 (en) 2023-08-14 2026-02-12 Intellia Therapeutics, Inc. Compositions and methods for genetically modifying transforming growth factor beta receptor type 2 (tgfβr2)
TW202521564A (zh) 2023-08-14 2025-06-01 美商英特利亞醫療公司 用於基於細胞之療法的cd70 car-t組合物及方法
TW202515994A (zh) 2023-08-14 2025-04-16 美商英特利亞醫療公司 用於對cd70進行基因修飾之組合物及方法
WO2025137301A1 (en) 2023-12-20 2025-06-26 Intellia Therapeutics, Inc. Methods for rapid engineering of cells
WO2025255308A1 (en) 2024-06-07 2025-12-11 Intellia Therapeutics, Inc. Cd8 co-receptor chimeric polypeptides in tcr cell therapy
WO2026014914A1 (ko) * 2024-07-10 2026-01-15 서울대학교산학협력단 Adar 효소 또는 이의 변이체를 이용한 단일 염기 교정기

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
MX374090B (es) * 2013-03-14 2025-03-05 Caribou Biosciences Inc Composiciones y métodos de ácidos nucleicos dirigidos al ácido nucleico.
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
JP7109784B2 (ja) * 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子編集のための進化したCas9蛋白質
KR102547316B1 (ko) 2016-08-03 2023-06-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
WO2018152197A1 (en) * 2017-02-15 2018-08-23 Massachusetts Institute Of Technology Dna writers, molecular recorders and uses thereof
KR102772726B1 (ko) 2017-02-15 2025-02-25 키진 엔.브이. 식물 세포에서 표적 유전적 변형 방법
CA3057192A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins

Similar Documents

Publication Publication Date Title
JP2022508716A5 (https=)
JPWO2020081568A5 (https=)
US20230279374A1 (en) Modified cas9 protein, and use thereof
Perelygin et al. Positional cloning of the murine flavivirus resistance gene
Elkon et al. Tumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors
Terranova et al. Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll
Lamm et al. Non-snRNP protein splicing factors
Jao et al. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system
Tang et al. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis
Cheng et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak
Laing et al. Expression of an inducible nitric oxide synthase gene in rainbow trout Oncorhynchus mykiss
WO2016004010A1 (en) Regulated gene expression from viral vectors
JP2019508051A5 (https=)
Rodriguez et al. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling
Garrido-Ramos Unstable microsatellite repeats facilitate rapid evolution of coding and regulatory sequences
Vestal The guanylate-binding proteins (GBPs): proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity
ATE211174T1 (de) Thymidin-kinase-mutanten
CN117222743A (zh) 向导RNA设计和用于无Tracr V型Cas系统的复合物
Zheng et al. The novel helicase helG (DHX30) is expressed during gastrulation in mice and has a structure similar to a human DExH box helicase
Jo et al. Therapeutic adenine base editing corrects nonsense mutation and improves visual function in a mouse model of Leber congenital amaurosis
WO2020208185A1 (en) Compositions and methods for improved gene editing
BR0008313A (pt) Composições e métodos para ativação não-direcionada de genes endógenos
Young et al. Replication and recombination in adenovirus-infected cells are temporally and functionally related
CA2327353A1 (en) Structural proteins of fish pancreatic disease virus and uses thereof
Neilan et al. An African swine fever virus gene with similarity to bacterial DNA binding proteins, bacterial integration host factors, and the Bacillus phage SPO1 transcription factor, TF1